A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine

N. Wells, J. Hettiarachchi, M. Drummond, D. Carter, T. Parpia, F. Pang

Research output: Contribution to journal › Article › peer-review

Cite this

@article{eb6c189b75244b2baaa741de0c65a862,

title = "A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine",

author = "N. Wells and J. Hettiarachchi and M. Drummond and D. Carter and T. Parpia and F. Pang",

year = "2003",

language = "English",

volume = "6",

pages = "438--447",

journal = "Value in Health",

issn = "1524-4733",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - A cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraine

AU - Wells, N.

AU - Hettiarachchi, J.

AU - Drummond, M.

AU - Carter, D.

AU - Parpia, T.

AU - Pang, F.

PY - 2003

Y1 - 2003

M3 - Article

SN - 1524-4733

VL - 6

SP - 438

EP - 447

JO - Value in Health

JF - Value in Health

IS - 4

ER -